Press Releases in 2011

Check out the latest press releases from Novus. For direct media requests, contact us at novus@novusbio.com.
View Press Releases From: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

Novus Biologicals Announces VMAT2 Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Tuesday, June 14, 2011 - 06:00

Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research.  This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM).

Novus Biologicals Announces LIPA Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Tuesday, May 31, 2011 - 06:00

Novus Biologicals announced today a new LIPA Antibody (NBP1-54155) for use as a liver and kidney marker in cholesterol metabolism research.  This LIPA antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Novus Biologicals Announces SDHB Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Friday, May 27, 2011 - 06:00

Novus Biologicals announced today a new SDHB Antibody (NBP1-54154) for use as a mitochondrial marker and for cancer research. This SDHB antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Novus Biologicals Announces MYOD1 Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Thursday, May 26, 2011 - 06:00

Novus Biologicals announced today a new MYOD1 Antibody (NBP1-54153) for use as a muscle cell marker and for cancer research. This MYOD1 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Novus Biologicals Announces STK33 Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Wednesday, May 25, 2011 - 06:00

Novus Biologicals announced today a new STK33 Antibody (NBP1-54156) for use as an embryonic germ-line cell and/or tumor marker.  This STK33 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Epi-PlusTM Antibody Line Unveiled by Novus Biologicals

Release Date: 
Friday, May 20, 2011 - 06:00

Novus Biologicals, a premier supplier of antibodies and related research products, announced today the release of a new product line for epigenetics research called Epi-PlusTM antibodies. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated antibodies for modified histones and other epigenetic targets.   

Novus Biologicals Adds University of Virginia as a Preferred Customer

Release Date: 
Monday, May 9, 2011 - 06:00

Novus Biologicals is excited to add the University of Virginia (UVA) to our Preferred Customer Program.  As a part of the Preferred Customer Program, Novus Biologicals will now provide UVA affiliated organizations with 5% off all orders and discounted shipping charges.

The Novus-UVA partnership is available to all UVA affiliated schools and researchers.  Amanda Jaramillo, Customer Service Manager for Novus, explained:

Novus Biologicals Announces New Mitofusin 1 Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Friday, May 6, 2011 - 06:00

Novus Biologicals announced today a new MFN1 Antibody (NBP1-51841) for use as a mitochondrial marker and in neuroscience research.  This MFN1 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Novus Biologicals Announces New MUC4 Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Thursday, May 5, 2011 - 06:00

Novus Biologicals announced today a new MUC4 antibody (catalog number NBP1-52193) for the study of Mucin 4 and cancer development.  This MUC-4 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Novus Biologicals Announces New Aurora A Antibody made using SDIX Genomic Antibodiesâ„¢

Release Date: 
Wednesday, May 4, 2011 - 06:00

Novus Biologicals announced today a new Aurora A antibody (catalog number NBP1-51843) for the study of kinase signal transduction and cell cycle regulation.  This Aurora A was made using SDIX Genomic Antibody TechnologyTM (GATTM). 

Pages